Compare Eli Lilly And Co (LLY) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs GeneDx Holdings Corp — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Eli Lilly And Co is far larger — about 566.7× GeneDx Holdings Corp's market cap, and Eli Lilly And Co pays a 0.6% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| LLY | WGS | |
|---|---|---|
Market Cap | $1.02T | $1.80B |
Sector | Health | Technology |
52-Week High | $1.24K | $167.51 |
52-Week Low | $625.65 | $34.51 |
Enterprise Value | $1.06T | $1.80B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
